170 related articles for article (PubMed ID: 30959357)
21. Therapeutic prospects of targeting myeloid-derived suppressor cells and immune checkpoints in cancer.
Toor SM; Elkord E
Immunol Cell Biol; 2018 Oct; 96(9):888-897. PubMed ID: 29635843
[TBL] [Abstract][Full Text] [Related]
22. Expression of checkpoint molecules on myeloid-derived suppressor cells.
Ballbach M; Dannert A; Singh A; Siegmund DM; Handgretinger R; Piali L; Rieber N; Hartl D
Immunol Lett; 2017 Dec; 192():1-6. PubMed ID: 28987474
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulatory effects of myeloid-derived suppressor cells in diseases: Role in cancer and infections.
Tamadaho RSE; Hoerauf A; Layland LE
Immunobiology; 2018; 223(4-5):432-442. PubMed ID: 29246400
[TBL] [Abstract][Full Text] [Related]
24. Granulocytic Myeloid-Derived Suppressor Cells (GR-MDSC) in Breast Milk (BM); GR-MDSC Accumulate in Human BM and Modulate T-Cell and Monocyte Function.
Köstlin N; Schoetensack C; Schwarz J; Spring B; Marmé A; Goelz R; Brodbeck G; Poets CF; Gille C
Front Immunol; 2018; 9():1098. PubMed ID: 29868036
[TBL] [Abstract][Full Text] [Related]
25. Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.
Grohová A; Dáňová K; Adkins I; Šumník Z; Petruželková L; Obermannová B; Koloušková S; Špíšek R; Palová-Jelínková L
PLoS One; 2020; 15(11):e0242092. PubMed ID: 33206686
[TBL] [Abstract][Full Text] [Related]
26. Plasticity of myeloid-derived suppressor cells in cancer.
Tcyganov E; Mastio J; Chen E; Gabrilovich DI
Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
[TBL] [Abstract][Full Text] [Related]
27. Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer.
Ko HJ; Kim YJ
Arch Pharm Res; 2016 Nov; 39(11):1597-1608. PubMed ID: 27572156
[TBL] [Abstract][Full Text] [Related]
28. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
Ostrand-Rosenberg S; Fenselau C
J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
[TBL] [Abstract][Full Text] [Related]
29. Myeloid-Derived Suppressor Cells in Pregnancy and the Neonatal Period.
Köstlin-Gille N; Gille C
Front Immunol; 2020; 11():584712. PubMed ID: 33162999
[TBL] [Abstract][Full Text] [Related]
30. TNFR1 Signaling Contributes to T Cell Anergy During
Ledo C; Gonzalez CD; Poncini CV; Mollerach M; Gómez MI
Front Cell Infect Microbiol; 2018; 8():259. PubMed ID: 30123776
[TBL] [Abstract][Full Text] [Related]
31. Myeloid-Derived Suppressor Cells Mediate Immunosuppression After Cardiopulmonary Bypass.
Hübner M; Tomasi R; Effinger D; Wu T; Klein G; Bender M; Kilger E; Juchem G; Schwedhelm E; Kreth S
Crit Care Med; 2019 Aug; 47(8):e700-e709. PubMed ID: 31149961
[TBL] [Abstract][Full Text] [Related]
32. Impaired antigen-specific lymphocyte priming in mice after Toll-like receptor 4 activation via induction of monocytic myeloid-derived suppressor cells.
Tsukamoto H; Kozakai S; Kobayashi Y; Takanashi R; Aoyagi T; Numasaki M; Ohta S; Tomioka Y
Eur J Immunol; 2019 Apr; 49(4):546-563. PubMed ID: 30671932
[TBL] [Abstract][Full Text] [Related]
33. Emerging Role of Immunosuppression in Diseases Induced by Micro- and Nano-Particles: Time to Revisit the Exclusive Inflammatory Scenario.
Huaux F
Front Immunol; 2018; 9():2364. PubMed ID: 30510551
[TBL] [Abstract][Full Text] [Related]
34. Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques.
Sui Y; Frey B; Wang Y; Billeskov R; Kulkarni S; McKinnon K; Rourke T; Fritts L; Miller CJ; Berzofsky JA
PLoS Pathog; 2017 May; 13(5):e1006395. PubMed ID: 28498847
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulatory effects of P2X7 receptor in intracellular parasite infections.
Savio LEB; Coutinho-Silva R
Curr Opin Pharmacol; 2019 Aug; 47():53-58. PubMed ID: 30901737
[TBL] [Abstract][Full Text] [Related]
36. RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells.
Soong RS; Anchoori RK; Yang B; Yang A; Tseng SH; He L; Tsai YC; Roden RB; Hung CF
Oncotarget; 2016 Oct; 7(42):68489-68502. PubMed ID: 27655678
[TBL] [Abstract][Full Text] [Related]
37. Staphylococcal Enterotoxins Dose-Dependently Modulate the Generation of Myeloid-Derived Suppressor Cells.
Stoll H; Ost M; Singh A; Mehling R; Neri D; Schäfer I; Velic A; Macek B; Kretschmer D; Weidenmaier C; Hector A; Handgretinger R; Götz F; Peschel A; Hartl D; Rieber N
Front Cell Infect Microbiol; 2018; 8():321. PubMed ID: 30271756
[No Abstract] [Full Text] [Related]
38. Phenotype and Function of Myeloid-Derived Suppressor Cells Induced by Porphyromonas gingivalis Infection.
Su L; Xu Q; Zhang P; Michalek SM; Katz J
Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28533469
[No Abstract] [Full Text] [Related]
39. AhR Activation Leads to Massive Mobilization of Myeloid-Derived Suppressor Cells with Immunosuppressive Activity through Regulation of CXCR2 and MicroRNA miR-150-5p and miR-543-3p That Target Anti-Inflammatory Genes.
Neamah WH; Singh NP; Alghetaa H; Abdulla OA; Chatterjee S; Busbee PB; Nagarkatti M; Nagarkatti P
J Immunol; 2019 Oct; 203(7):1830-1844. PubMed ID: 31492743
[TBL] [Abstract][Full Text] [Related]
40. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection.
Tebartz C; Horst SA; Sparwasser T; Huehn J; Beineke A; Peters G; Medina E
J Immunol; 2015 Feb; 194(3):1100-11. PubMed ID: 25548227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
